Literature DB >> 33782035

Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD.

Monique E Cho1,2, Jared L Hansen3,4, Brian C Sauer3,4, Alfred K Cheung5,2, Adhish Agarwal2, Tom Greene4.   

Abstract

BACKGROUND AND OBJECTIVES: CKD is an independent risk factor for heart failure. Iron dysmetabolism potentially contributes to heart failure, but this relationship has not been well characterized in CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a historical cohort study using data from the Veterans Affairs Corporate Data Warehouse to evaluate the relationship between iron status and heart failure hospitalization. We identified a CKD cohort with at least one set of iron indices between 2006 and 2015. The first available date of serum iron indices was identified as the study index date. The cohort was divided into four iron groups on the basis of the joint quartiles of serum transferrin saturation (shown in percent) and ferritin (shown in nanograms per milliliter): reference (16%-28%, 55-205 ng/ml), low iron (0.4%-16%, 0.9-55 ng/ml), high iron (28%-99.5%, 205-4941 ng/ml), and function iron deficiency (0.8%-16%, 109-2783 ng/ml). We compared 1-year heart failure hospitalization risk between the iron groups using matching weights derived from multinomial propensity score models and Poisson rate-based regression.
RESULTS: A total of 78,551 veterans met the eligibility criteria. The covariates were well balanced among the iron groups after applying the propensity score weights (n=31,819). One-year adjusted relative rate for heart failure hospitalization in the iron deficiency groups were higher compared with the reference group (low iron: 1.29 [95% confidence interval, 1.19 to 1.41]; functional iron deficiency: 1.25 [95% confidence interval, 1.13 to 1.37]). The high-iron group was associated with lower 1-year relative rate of heart failure hospitalization (0.82; 95% confidence interval, 0.72 to 0.92). Furthermore, the association between iron deficiency and heart failure hospitalization risk remained consistent regardless of the diabetes status or heart failure history at baseline.
CONCLUSIONS: Iron deficiency, regardless of cause, was associated with higher heart failure hospitalization risk in CKD. Higher iron status was associated with lower heart failure hospitalization risks.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  CKD; chronic kidney disease; heart failure; hospitalization; iron; veterans

Mesh:

Substances:

Year:  2021        PMID: 33782035      PMCID: PMC8092060          DOI: 10.2215/CJN.15360920

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  32 in total

1.  Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.

Authors:  Aidan P Bolger; Frederick R Bartlett; Helen S Penston; Justin O'Leary; Noel Pollock; Raffi Kaprielian; Callum M Chapman
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

2.  The impact of varying degrees of iron nutriture on several functional consequences of iron deficiency in rats.

Authors:  M J Borel; S H Smith; D E Brigham; J L Beard
Journal:  J Nutr       Date:  1991-05       Impact factor: 4.798

3.  Propensity score weighting with multilevel data.

Authors:  Fan Li; Alan M Zaslavsky; Mary Beth Landrum
Journal:  Stat Med       Date:  2013-03-24       Impact factor: 2.373

4.  Distinguishing effects of anemia and muscle iron deficiency on exercise bioenergetics in the rat.

Authors:  K J Davies; C M Donovan; C J Refino; G A Brooks; L Packer; P R Dallman
Journal:  Am J Physiol       Date:  1984-06

5.  Association of markers of iron stores with outcomes in patients with nondialysis-dependent chronic kidney disease.

Authors:  Csaba P Kovesdy; Wilber Estrada; Shahram Ahmadzadeh; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

6.  ESRD and death after heart failure in CKD.

Authors:  Maneesh Sud; Navdeep Tangri; Melania Pintilie; Andrew S Levey; David M J Naimark
Journal:  J Am Soc Nephrol       Date:  2014-09-04       Impact factor: 10.121

7.  Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

Authors:  Anna Kottgen; Stuart D Russell; Laura R Loehr; Ciprian M Crainiceanu; Wayne D Rosamond; Patricia P Chang; Lloyd E Chambless; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2007-03-07       Impact factor: 10.121

8.  Adjusting for overdispersion in piecewise exponential regression models to estimate excess mortality rate in population-based research.

Authors:  Miguel Angel Luque-Fernandez; Aurélien Belot; Manuela Quaresma; Camille Maringe; Michel P Coleman; Bernard Rachet
Journal:  BMC Med Res Methodol       Date:  2016-10-01       Impact factor: 4.615

9.  Propensity score analysis with partially observed covariates: How should multiple imputation be used?

Authors:  Clémence Leyrat; Shaun R Seaman; Ian R White; Ian Douglas; Liam Smeeth; Joseph Kim; Matthieu Resche-Rigon; James R Carpenter; Elizabeth J Williamson
Journal:  Stat Methods Med Res       Date:  2017-06-02       Impact factor: 3.021

10.  Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006.

Authors:  Catherine Kim; Kai McKeever Bullard; William H Herman; Gloria L Beckles
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

View more
  3 in total

1.  Intravenous Iron-Carbohydrate Nanoparticles and Their Similars. What Do We Choose?

Authors:  Ana Maria Mehedinti; Cristina Capusa; Iuliana Andreiana; Gabriel Mircescu
Journal:  Maedica (Bucur)       Date:  2022-06

2.  A New View of Iron Management in Heart Failure: What Nephrologists Need to Know.

Authors:  Nupur N Uppal; Steven Fishbane
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

Review 3.  Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action.

Authors:  Patrice Cacoub; Gabriel Choukroun; Alain Cohen-Solal; Elisabeth Luporsi; Laurent Peyrin-Biroulet; Katell Peoc'h; Valérie Andrieu; Sigismond Lasocki; Hervé Puy; Jean-Noël Trochu
Journal:  J Intern Med       Date:  2022-05-03       Impact factor: 13.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.